Nov. 3, 2025 /Mpelembe Media/ — Doomscrolling (or doomsurfing) is the act of spending an excessive amount of time reading or watching a large quantity of negative, distressing, or alarming news and content online, particularly on social media and news websites. Continue reading
With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help tech journalists and consumers stay on top of the week’s most newsworthy and popular releases, here’s a recap of some major stories from the week that shouldn’t be missed. Continue reading
With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help finance journalists and consumers stay on top of the week’s most newsworthy and popular releases, here’s a recap of some major stories from the week that shouldn’t be missed. Continue reading
With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help finance journalists and consumers stay on top of the month’s most popular releases and newsworthy trends, here’s a recap of some of the past month’s most read- and engaged-with stories. Continue reading
With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help finance journalists and consumers stay on top of the week’s most newsworthy and popular releases, here’s a recap of some major stories from the week that shouldn’t be missed. Continue reading
With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help tech journalists and consumers stay on top of the week’s most newsworthy and popular releases, here’s a recap of some major stories from the week that shouldn’t be missed. Read more
Jan. 3, 2025 /Mpelembe Media/ — Oncolytics Biotech Inc.’s progress in developing cutting-edge immunotherapies for cancer treatment is the article’s main subject. The piece highlights several key advancements, including clinical trial results and collaborations with other companies. Financial information regarding Oncolytics is included, along with a disclaimer about the nature of the publication. Continue reading
With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help tech journalists and consumers stay on top of the week’s most newsworthy and popular releases, here’s a recap of some major stories from the week that shouldn’t be missed. Continue reading
With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help healthcare journalists and consumers stay on top of the week’s most newsworthy and popular releases, here’s a recap of some major stories from the week that shouldn’t be missed. Continue reading
With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help tech journalists and consumers stay on top of the week’s most newsworthy and popular releases, here’s a recap of some major stories from the week that shouldn’t be missed. Continue reading